ISPOR - Cost Utility Of Diabetes Drugs Using Hba1c As A Direct Predictor For Quality Of Life, Diabetes Complications And Mortality

Full Text

Cost Utility Of Diabetes Drugs Using Hba1c As A Direct Predictor For Quality Of Life, Diabetes Complications And Mortality

Abstract

Authors

H Kim L Gurrin D Magliano D Liew

Back to Volume 17, Issue 7

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now